Absolutely and not because they want to, it’s a case of have to. Under fda guidelines, stem cells for regenerative treatments may be shut down late 2020, that forces them down the fda trial route. The good thing is they pred are best in class, have treated thousands of people with no safety issues which may allow them to enter fast tract fda trials.
In the shirt term, it’s all about endometriosis and fertility. Wouldn’t be surprised if we seen spin offs here as big pharma investors see stem cells as a liability. Throw in China and fertility is enough to make everyone extremely happy over the coming years